Condomless Sex in HIV-diagnosed Men Who Have Sex with Men in the UK: Prevalence, Correlates, and Implications for HIV Transmission
Overview
Authors
Affiliations
Objective: HIV transmission is ongoing among men who have sex with men (MSM) in the UK. Sex without a condom (condomless sex, CLS) is the main risk factor. We investigated the prevalence of and factors associated with types of CLS.
Methods: Cross-sectional questionnaire study in UK HIV clinics in 2011/2012 (ASTRA). MSM diagnosed with HIV for ≥3 months reported on anal and vaginal sex, CLS with HIV-serodifferent partners (CLS-D) and CLS with HIV-seroconcordant (CLS-C) partners in the previous 3 months. Mutually exclusive sexual behaviours were as follows: (1) Higher HIV risk CLS-D (not on antiretroviral therapy (ART) or clinic-recorded viral load(VL) >50 c/mL), (2) Other CLS-D, (3) CLS-C without CLS-D, (4) Condom-protected sex only and (5) No anal or vaginal sex. Associations were examined of sociodemographic, HIV-related, lifestyle, and other sexual measures with the five categories of sexual behaviour. We examined the prevalence of higher HIV risk CLS-D incorporating (in addition to ART and VL) time on ART, ART non-adherence, and recent sexually transmitted infections (STIs).
Results: Among 2189 HIV-diagnosed MSM (87% on ART), prevalence of any CLS in the past 3 months was 38.2% (95% CI 36.2% to 40.4%) and that of any CLS-D was 16.3% (14.8%-17.9%). The five-category classification was as follows: (1) Higher HIV risk CLS-D: 4.2% (3.5% to 5.2%), (2) Other CLS-D: 12.1% (10.8% to 13.5%), (3) CLS-C without CLS-D: 21.9% (20.2% to 23.7%), (4) Condom-protected sex only: 25.4% (23.6% to 27.3%) and (5) No anal or vaginal sex: 36.4% (34.3% to 38.4%). Compared with men who reported condom-protected sex only, MSM who reported any CLS in the past 3 months had higher prevalence of STIs, chemsex-associated drug use, group sex, higher partner numbers, and lifetime hepatitis C. Prevalence of higher HIV risk CLS-D ranged from 4.2% to 7.5% according to criteria included.
Conclusion: CLS was prevalent among HIV-diagnosed MSM, but CLS-D with higher HIV transmission risk was overall low. CLS-D is no longer the most appropriate measure of HIV transmission risk behaviour among people with diagnosed HIV; accounting for VL is important.
Gertzen M, Karcher S, Schwarz J, Rosenberger C, Strasburger M, Rabenstein A Brain Sci. 2024; 14(7).
PMID: 39061406 PMC: 11275116. DOI: 10.3390/brainsci14070666.
Amplified HIV Transmission Risk Among People Living With HIV in Southeast Brazil.
Reis R, Antonini M, Sousa L, de Alencar Rocha K, Ferreira G, Vettore M J Assoc Nurses AIDS Care. 2023; 34(5):469-480.
PMID: 37565984 PMC: 10470434. DOI: 10.1097/JNC.0000000000000421.
Kwan T, Wong B, Wong K, Lee S Front Public Health. 2022; 10:925600.
PMID: 35719672 PMC: 9204175. DOI: 10.3389/fpubh.2022.925600.
Sumray K, Lloyd K, Estcourt C, Burns F, Gibbs J Sex Transm Infect. 2022; .
PMID: 35701146 PMC: 9613868. DOI: 10.1136/sextrans-2021-055376.
Durham M, Armon C, Novak R, Mahnken J, Carlson K, Li J AIDS Behav. 2022; 26(10):3199-3209.
PMID: 35364730 PMC: 10246446. DOI: 10.1007/s10461-022-03655-z.